Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma.

MLA

Cheng, Zhe, et al. “Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma.” Pharmaceuticals (14248247), vol. 16, no. 5, May 2023, p. 644. EBSCOhost, https://doi.org/10.3390/ph16050644.

APA

Cheng, Z., Huang, H., Li, M., Liang, X., Tan, Y., & Chen, Y. (2023). Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma. Pharmaceuticals (14248247), 16(5), 644. https://doi.org/10.3390/ph16050644

Chicago

Cheng, Zhe, Huichao Huang, Maoyu Li, Xujun Liang, Yuying Tan, and Yongheng Chen. 2023. “Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma.” Pharmaceuticals (14248247) 16 (5): 644. doi:10.3390/ph16050644.